Literature DB >> 12475810

Hypoxic activation of adventitial fibroblasts: role in vascular remodeling.

Kurt R Stenmark1, Evgenia Gerasimovskaya, Raphael A Nemenoff, Mita Das.   

Abstract

Substantial experimental evidence supports the idea that the fibroblast may play a significant role in the vascular response to injury, especially under hypoxic conditions. Fibroblasts have the ability to rapidly respond to hypoxic stress and to modulate their function to adapt rapidly to local vascular needs. Fibroblasts appear to be uniquely equipped to proliferate, transdifferentiate, and migrate under hypoxic conditions. Proliferative responses to hypoxia depend on the activation of Galpha(i) and Gq kinase family members, and on the subsequent stimulation of protein kinase C and mitogen-activated protein kinase family members. Extracellular nucleotides (eg, adenosine triphosphate [ATP]) are likely to be increased in the hypoxic adventitial compartment and can act as autocrine/paracrine modifiers of the hypoxia-induced proliferative response. The proliferative effects of ATP appear to be mediated largely through G-protein-coupled P2Y receptors in fetal and neonatal fibroblasts. Hypoxia, acting through Galpha(iota)-coupled pathways, also can directly up-regulate alpha-smooth muscle actin expression in fibroblast subpopulations, suggesting that hypoxia may play a direct role in mediating the "transdifferentiation" of fibroblasts into myofibroblasts in the vessel wall. In addition, chronic hypoxia causes stable (at least in vitro) phenotypic changes in fibroblasts that appear to be associated with changes in the signaling pathways used to elicit proliferation. However, it is also becoming clear that, similar to the heterogeneity described for vascular smooth muscle cells, numerous fibroblast subtypes exist in the vessel wall, and that each may respond in unique ways to hypoxia and other stimuli and thus serve special functions in response to injury. In fact, adventitia may be considered to be compartments in which cells with "stem-cell-like" characteristics reside. Future work is needed to determine more precisely the role of the fibroblast in the wide variety of vascular complications observed in many humans diseases, and in the genes and gene products that confer unique properties to this important vascular cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475810     DOI: 10.1378/chest.122.6_suppl.326s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  43 in total

1.  Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.

Authors:  Michael L Paffett; Selita N Lucas; Matthew J Campen
Journal:  Vascul Pharmacol       Date:  2011-11-25       Impact factor: 5.773

2.  ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors.

Authors:  David Lu; Sahar Soleymani; Rohit Madakshire; Paul A Insel
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

3.  Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access.

Authors:  Sanjay Misra; Alex A Fu; Khamal D Misra; Uday M Shergill; Edward B Leof; Debabrata Mukhopadhyay
Journal:  J Vasc Interv Radiol       Date:  2010-06       Impact factor: 3.464

Review 4.  PDGF signaling in pulmonary arterial hypertension.

Authors:  Robyn J Barst
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

5.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

Review 6.  Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.

Authors:  David Lu; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-18       Impact factor: 4.249

Review 7.  Significance of main pulmonary artery dilation on imaging studies.

Authors:  Timothy E Raymond; Joseph E Khabbaza; Ruchi Yadav; Adriano R Tonelli
Journal:  Ann Am Thorac Soc       Date:  2014-12

Review 8.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Time course of intermittent hypoxia-induced impairments in resistance artery structure and function.

Authors:  Nathan R Philippi; Cynthia E Bird; Noah J Marcus; E Burt Olson; Naomi C Chesler; Barbara J Morgan
Journal:  Respir Physiol Neurobiol       Date:  2009-12-05       Impact factor: 1.931

Review 10.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.